HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Vihola Selected Research

Type 2J Limb-Girdle Muscular Dystrophy

7/2015CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy.
2/2014Atypical phenotypes in titinopathies explained by second titin mutations.
9/2010Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies.
6/2008Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Vihola Research Topics

Disease

14Distal Myopathies (Distal Muscular Dystrophy)
08/2022 - 09/2002
7Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
11/2017 - 06/2008
6Muscular Diseases (Myopathy)
01/2021 - 06/2008
4Muscular Dystrophies (Muscular Dystrophy)
07/2019 - 10/2015
4Type 2J Limb-Girdle Muscular Dystrophy
07/2015 - 06/2008
2Contracture
07/2019 - 12/2015
2Limb-girdle muscular dystrophy type 2A
07/2015 - 09/2010
2Myotonic Dystrophy (Dystrophia Myotonica)
12/2010 - 04/2010
1Inclusion Body Myositis
08/2022
1Muscle Weakness
01/2021
1Type 1F Limb-Girdle Muscular Dystrophy
06/2019
1Mitochondrial Myopathies (Mitochondrial Myopathy)
11/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Hereditary Myopathy with Early Respiratory Failure
06/2012
1Type 1D Limb-Girdle Muscular Dystrophy
02/2012
1Myofibrillar Myopathy
02/2012
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
09/2010
1Cardiomyopathies (Cardiomyopathy)
09/2010
1Early-Onset Myopathy with Fatal Cardiomyopathy
06/2008

Drug/Important Bio-Agent (IBA)

12ConnectinIBA
01/2018 - 09/2002
10Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2002
3CalpainIBA
12/2015 - 09/2010
2RNA (Ribonucleic Acid)IBA
08/2022 - 04/2010
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2020 - 01/2019
2Protein Isoforms (Isoforms)IBA
10/2015 - 02/2012
2Peptide Hydrolases (Proteases)FDA Link
07/2015 - 09/2010
2Messenger RNA (mRNA)IBA
02/2014 - 04/2010
1CalciumIBA
08/2022
1nebulinIBA
01/2021
1Muscle Proteins (Muscle Protein)IBA
01/2021
1CollagenIBA
07/2019
1Codon (Codons)IBA
06/2019
1Mitochondrial DNA (mtDNA)IBA
11/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1AnoctaminsIBA
06/2013
1DysferlinIBA
06/2013
1RNA-Binding Proteins (RNA-Binding Protein)IBA
04/2013
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
09/2010

Therapy/Procedure

1Therapeutics
04/2015